PSUSA/00001041/202501
Submitted by Anonymous (not verified) on 12 September 2025 - 10:58
PSUSA/00001041/202501
Product Management Service (PMS) roadmap
Submitted by Anonymous (not verified) on 12 September 2025 - 10:25
Product Management Service (PMS) roadmap
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 12 September 2025 - 10:10
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 3, Status: Authorised
PSUSA/00010287/202411
Submitted by Anonymous (not verified) on 11 September 2025 - 16:56
PSUSA/00010287/202411
PSUSA/00000427/202412
Submitted by Anonymous (not verified) on 11 September 2025 - 16:46
PSUSA/00000427/202412
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 11 September 2025 - 15:31
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Champix, varenicline, Date of authorisation: 25/09/2006, Revision: 39, Status: Authorised
Submitted by Anonymous (not verified) on 11 September 2025 - 15:16
Human medicines European public assessment report (EPAR): Champix, varenicline, Date of authorisation: 25/09/2006, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 11 September 2025 - 15:15
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 11 September 2025 - 14:55
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of authorisation: 02/06/2025, Status: Authorised
Submitted by Anonymous (not verified) on 11 September 2025 - 10:42
Human medicines European public assessment report (EPAR): Ryjunea, atropine sulfate, Date of authorisation: 02/06/2025, Status: Authorised